Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-16

Clinical Trial Update: Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of a diosmin/hesperidin combination on clinical outcomes in polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • diosmin/hesperidin combination

Snippet

Sponsor: Ain Shams University | Conditions: Poly Cystic Ovary Syndrome | Phase 4 | Status: UNKNOWN